Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy

BACKGROUND: Calls for the coronavirus to be treated as an endemic illness, such as the flu, are increasing. After achieving high coverage of COVID-19 vaccination, therapeutic drugs have become important for future SARS-CoV-2 variant outbreaks. Although many monoclonal antibodies have been approved f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Chen-Yi, Chen, Mei-Yu, Hsu, Chia-Wei, Liu, Chia-Yeh, Tsai, Yu-Wen, Liao, Hung-Chun, Yan, Jia-Ying, Chuang, Zih-Shiuan, Wang, Hsin-I., Pan, Chien-Hsiung, Yu, Chia-Yi, Yu, Guann-Yi, Liao, Ching-Len, Liu, Shih-Jen, Chen, Hsin-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178533/
https://www.ncbi.nlm.nih.gov/pubmed/35681239
http://dx.doi.org/10.1186/s12929-022-00823-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178533/
https://www.ncbi.nlm.nih.gov/pubmed/35681239
http://dx.doi.org/10.1186/s12929-022-00823-0

Ejemplares similares